FDAClass IIJuly 23, 2025

Levothyroxine Sodium Tablets recall: Subpotent

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617…

Why was Levothyroxine Sodium Tablets recalled?

Subpotent Drug: Assay below the approved specification

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #D2300042, Exp Date: 12/31/2025

Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617…
Recalling firm
ACCORD HEALTHCARE, INC.
Quantity
2,344 bottles
Distribution
Nationwide in the USA
Recall date
July 23, 2025
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls